Using a combination of functional studies and single cell analysis, a recent murine PDAC study demonstrated that hypoxia inducible factor signaling in cancer-associated fibroblasts drives CD86 and PDL1 expression on tumor associated macrophages (55) to dampen anti-tumor immune responses. Here, CD86 is linked to neoplasm.